JW Pharmaceutical Corp (001067.KS)
JW Pharmaceutical Corporation manufactures and sells medicines and medical supplies in Japan and internationally. It offers products in the areas of cancer, immunological disease, cardiovascular system and metabolic diseases, regenerative medicine, eye diseases , and pancreatic cancer. The company also offers infant care system, gynecological examining table, operating room equipment, steam sterilizer, and other equipment. In addition, it offers wound care, pain care, and beauty care related products. The company was founded in 1945 and is based in Gwacheon-si, South Korea.
Company Info
Highlights
₩548.26B
₩724.02B
₩324.65B
₩52,792.16 - ₩63,200.00
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
Loading data...
Returns By Period
JW Pharmaceutical Corp (001067.KS) returned 3.79% year-to-date (YTD) and 7.97% over the past 12 months. Over the past 10 years, 001067.KS delivered an annualized return of 12.69%, outperforming the S&P 500 benchmark at 10.85%.
001067.KS
3.79%
3.28%
3.40%
7.97%
-2.07%
10.65%
12.69%
^GSPC (Benchmark)
0.51%
3.96%
-2.00%
12.02%
12.68%
14.19%
10.85%
Monthly Returns
The table below presents the monthly returns of 001067.KS, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 2.31% | -2.25% | -0.16% | 0.00% | 3.96% | 3.79% | |||||||
| 2024 | -1.77% | -0.33% | -2.47% | 0.34% | -1.18% | -4.76% | 2.50% | 0.17% | 1.04% | 1.55% | 4.07% | -0.38% | -1.50% |
| 2023 | -5.53% | -1.79% | 0.61% | 6.27% | 1.12% | -5.36% | 7.50% | 0.47% | -2.78% | -1.90% | 2.43% | 0.73% | 0.88% |
| 2022 | -1.82% | 7.41% | 8.31% | 1.16% | 2.86% | 0.14% | -0.83% | -0.42% | -11.67% | 3.82% | -3.22% | 3.76% | 8.22% |
| 2021 | -0.73% | 5.50% | 12.17% | 9.92% | 0.99% | 0.14% | -15.20% | 5.10% | -12.36% | -0.18% | 3.40% | 8.41% | 14.14% |
| 2020 | 2.80% | -3.56% | -7.26% | 9.68% | 5.68% | 29.52% | 10.25% | 75.48% | -24.75% | -25.97% | -3.77% | -3.08% | 38.76% |
| 2019 | 12.38% | -6.22% | -1.16% | 10.71% | -2.23% | -6.63% | -5.59% | -7.77% | 8.82% | -3.69% | 2.68% | 5.77% | 4.35% |
| 2018 | 1.06% | -4.20% | -2.19% | 1.62% | 9.67% | 6.92% | 5.43% | -5.45% | -5.34% | -15.60% | 15.99% | -5.15% | -1.13% |
| 2017 | -2.40% | -4.39% | -2.70% | -1.67% | 10.17% | -4.62% | -0.13% | 36.20% | -10.38% | 2.65% | 0.54% | -6.85% | 9.95% |
| 2016 | -5.01% | -18.29% | -3.16% | -4.74% | 24.42% | -1.25% | -2.28% | 5.70% | 2.94% | -15.48% | 8.17% | 6.02% | -9.33% |
| 2015 | -3.48% | 20.66% | 4.35% | 15.89% | 16.63% | 26.01% | -7.65% | -1.99% | 9.46% | -1.23% | 26.72% | 16.69% | 199.48% |
| 2014 | 0.93% | 1.84% | 0.00% | -1.81% | 6.75% | -8.91% | -0.95% | 0.00% | 4.14% | -1.83% | 4.36% | -0.15% | 3.56% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of 001067.KS is 64, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for JW Pharmaceutical Corp (001067.KS) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Loading data...
Dividends
Dividend History
JW Pharmaceutical Corp provided a 0.71% dividend yield over the last twelve months, with an annual payout of ₩450.00 per share. The company has been increasing its dividends for 10 consecutive years.
| Period | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | ₩450.00 | ₩450.00 | ₩400.00 | ₩356.94 | ₩309.35 | ₩291.59 | ₩291.59 | ₩291.59 | ₩246.73 | ₩219.90 | ₩123.19 | ₩97.77 |
Dividend yield | 0.71% | 0.74% | 0.64% | 0.58% | 0.54% | 0.57% | 0.79% | 0.82% | 0.68% | 0.66% | 0.33% | 0.79% |
Monthly Dividends
The table displays the monthly dividend distributions for JW Pharmaceutical Corp. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | |||||||
| 2024 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩450.00 | ₩450.00 |
| 2023 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩400.00 | ₩400.00 |
| 2022 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩356.94 | ₩356.94 |
| 2021 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩309.35 | ₩309.35 |
| 2020 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩291.59 | ₩291.59 |
| 2019 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩291.59 | ₩291.59 |
| 2018 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩291.59 | ₩291.59 |
| 2017 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩246.73 | ₩246.73 |
| 2016 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩219.90 | ₩219.90 |
| 2015 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩123.19 | ₩123.19 |
| 2014 | ₩97.77 | ₩97.77 |
Dividend Yield & Payout
Dividend Yield
JW Pharmaceutical Corp has a dividend yield of 0.71%, which signifies it pays a smaller percentage of its stock price in dividends to its shareholders compared to other companies in the market.
Payout Ratio
JW Pharmaceutical Corp has a payout ratio of 17.70%, which is below the market average. This means JW Pharmaceutical Corp returns a smaller proportion of its earnings to shareholders as dividends, suggesting it retains a higher portion for reinvestment, growth, or debt payment.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading data...
Worst Drawdowns
The table below displays the maximum drawdowns of the JW Pharmaceutical Corp. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the JW Pharmaceutical Corp was 78.34%, occurring on Oct 11, 2004. Recovery took 182 trading sessions.
The current JW Pharmaceutical Corp drawdown is 51.68%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -78.34% | Feb 14, 2001 | 762 | Oct 11, 2004 | 182 | Sep 12, 2005 | 944 |
| -75.46% | May 20, 2008 | 113 | Oct 30, 2008 | 1530 | May 20, 2015 | 1643 |
| -65.46% | Aug 13, 2020 | 281 | Oct 5, 2021 | — | — | — |
| -63.05% | Nov 13, 2007 | 61 | Feb 14, 2008 | 46 | May 19, 2008 | 107 |
| -56.73% | Sep 13, 2005 | 165 | Feb 20, 2007 | 60 | Jul 18, 2007 | 225 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading data...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of JW Pharmaceutical Corp over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how JW Pharmaceutical Corp is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for 001067.KS relative to other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, 001067.KS has a P/S ratio of 0.8. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for 001067.KS in comparison with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, 001067.KS has a P/B value of 4.4. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |